Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry.
Jeffrey D JenksDanila SeidelOliver Andreas CornelySharon ChenSebastiaan van HalCarol KauffmanMarisa H MiceliMelina HeinemannMartin ChristnerAlfredo Jover SáenzAlexander BurchardtBjörn KemmerlingRaoul HerbrechtJoerg SteinmannShmuel ShohamSandra GräberLivio PaganoDries DeerenMonica A SlavinMartin HoeniglPublished in: Mycoses (2020)
Lomentospora prolificans infections were associated with mortality rates of 77% and above in patients with underlying haematological/oncological malignancies and those with disseminated infections. While combination therapy is the preferred option for now, the hope lies with novel antifungals currently under development.